+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Irbesartan"

Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Investigation Report on China's Irbesartan Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Irbesartan Market, 2018-2022

  • Report
  • September 2018
  • 30 Pages
  • China
From
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • November 2023
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 109 Pages
  • China
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Irbesartan is a medication used to treat high blood pressure and heart failure. It belongs to a class of drugs known as angiotensin receptor blockers (ARBs). ARBs work by blocking the action of a hormone called angiotensin II, which causes blood vessels to narrow and increases blood pressure. Irbesartan is also used to reduce the risk of stroke in people with high blood pressure and left ventricular hypertrophy, a condition in which the heart's left ventricle is enlarged. Irbesartan is available as a generic drug and is marketed under several brand names, including Avapro, Karvea, and Aprovel. It is available in tablet form and is usually taken once or twice daily. In the Irbesartan market, some of the companies include Sanofi, Bristol-Myers Squibb, Daiichi Sankyo, and Teva Pharmaceuticals. Show Less Read more